On October 8, 2024, the Union Ayush Ministry emphasized that it is illegal to advertise Ayurveda, Siddha, Unani, and Homeopathy (ASU&H) medicines by making claims of “miraculous or supernatural effects” for treating diseases. These types of advertisements are misleading and can jeopardize public health by promoting unverified or false claims, according to a public notice issued by the Ministry.

The notice further clarified that the Ayush Ministry neither certifies nor approves any ASU&H company or its medicines. Additionally, it does not grant licenses for the manufacture or sale of ASU&H products. Instead, the responsibility for licensing falls under the jurisdiction of the State and Union Territory Licensing Authorities, as stipulated by the Drugs and Cosmetics Act, 1940, and the corresponding rules. This regulation ensures that the manufacture and sale of ASU&H drugs are governed by the respective local authorities, reinforcing the fact that central government certification is not part of the process.

“It is illegal to advertise ASU&H drugs claiming miraculous or supernatural effects for the treatment of diseases. Such advertisements can mislead and endanger public health by promoting unverified or false claims,” the Ministry stated, highlighting the potential dangers of misleading information.

The Drugs and Magic Remedies (Objectionable Advertisements) Act of 1954 serves as a legal framework prohibiting the advertisement of drugs and magic remedies for the treatment of specific diseases and conditions. This law is designed to protect consumers from false claims that could lead to self-diagnosis or the inappropriate use of medicines, potentially resulting in harm.

Violations of the Drugs and Magic Remedies Act carry penalties as prescribed by law. Those found guilty of advertising prohibited drugs or making unverified health claims may face legal consequences. The Ministry of Ayush made it clear that they take these matters seriously and are committed to enforcing the law to safeguard public health.

ASU&H drugs that contain Schedule E1 substances, which have stronger pharmacological effects, are required to be used under the strict supervision of a registered medical practitioner specializing in the relevant Ayush system of medicine. This ensures that the medications are used appropriately and that patients receive the necessary guidance for their treatment.

According to the public notice, the packaging of such medicines must display a label with a clear warning in both Hindi and English: "Caution to be taken under medical supervision." This labeling requirement reinforces the need for patients to consult with licensed professionals before using these medications.

The Ayush Ministry also advised the general public to seek medical advice from registered practitioners before using ASU&H drugs. The Ministry urged individuals not to self-diagnose or self-medicate using these products, as this practice can lead to complications and potentially worsen health conditions. By consulting qualified professionals, individuals can ensure they receive the proper treatment tailored to their specific medical needs.

Furthermore, the Ministry encouraged the public to report any objectionable advertisements, false claims, or fake medicines to the relevant State Licensing Authority or the Ministry of Ayush. This reporting mechanism allows authorities to take appropriate action against those violating the law or engaging in deceptive practices.

The Ayush Ministry’s stance on the responsible advertising and use of ASU&H medicines reflects its commitment to protecting public health and maintaining the integrity of traditional Indian medicine systems. By reinforcing the importance of medical supervision, appropriate advertising practices, and compliance with legal standards, the Ministry aims to prevent the spread of misinformation and the misuse of ASU&H drugs.

In summary, the Ayush Ministry is focused on ensuring that Ayurvedic, Siddha, Unani, and Homeopathic medicines are used safely and appropriately. By banning advertisements that make unfounded claims and urging the public to consult registered practitioners, the Ministry seeks to prevent health risks associated with misinformation and self-medication.

(Input from various sources)

(Rehash/Yash Kamble/MSM)